Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03338972||Recruiting||Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma||
||Other / Industry / NIH||
||25||All||21 Years and older (Adult, Older Adult)||NCT03338972||9762
|November 29, 2017||December 15, 2020||December 15, 2022||November 9, 2017||May 15, 2019||